<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38100537</article-id><article-id pub-id-type="pmc">PMC10732210</article-id>
<article-id pub-id-type="doi">10.1080/13880209.2023.2292256</article-id><article-id pub-id-type="publisher-id">2292256</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Nicotinamide mononucleotide alleviates endotoxin-induced acute lung injury by modulating macrophage polarization via the SIRT1/NF-&#x003ba;B pathway</article-title><alt-title alt-title-type="left-running-head">S. He et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>He</surname><given-names>Simeng</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AUFN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Xianhong</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AUFN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jing</given-names></name><xref rid="AF0002" ref-type="aff">b</xref><xref rid="AUFN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Ya</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Jia</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Xiaoyang</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Shihan</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuan</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Lirong</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Shuan</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0530-6749</contrib-id><name><surname>Yu</surname><given-names>Jianbo</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AN0001" ref-type="corresp"/></contrib><aff id="AF0001"><label>a</label><institution>Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University</institution>, <city>Tianjin</city>, <country>China</country></aff><aff id="AF0002"><label>b</label><institution>Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Institute of Acute Abdominal Diseases of Integrated Traditional Chinese and Western Medicine, Tianjin Nankai Hospital</institution>, <city>Tianjin</city>, <country>China</country></aff></contrib-group><author-notes><fn id="AUFN1"><label>*</label><p>These authors contributed equally to this work.</p></fn><corresp id="AN0001">CONTACT Jianbo Yu <email xlink:href="mailto:30717008@nankai.edu.cn">30717008@nankai.edu.cn</email><institution>Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University</institution>, <addr-line>6 Changjiang Road</addr-line>, <city>Tianjin</city>
<postal-code>300100</postal-code>, <country>China</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>12</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>12</month><year>2023</year></pub-date><volume>62</volume><issue>1</issue><fpage seq="3">22</fpage><lpage>32</lpage><pub-history><event event-type="received"><date><day>19</day><month>12</month><year>2022</year></date></event><event event-type="revised"><date><day>4</day><month>10</month><year>2023</year></date></event><event event-type="accepted"><date><day>3</day><month>12</month><year>2023</year></date></event><event event-type="tagger"><event-desc>KnowledgeWorks Global Ltd.</event-desc><date><day>14</day><month>12</month><year>2023</year></date></event><event event-type="build-issue-online"><event-desc>published online in a building issue</event-desc><date><day>14</day><month>12</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#x000a9; 2023 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IPHB_62_2292256.pdf"/><abstract><title>Abstract</title><sec><title>Context</title><p>Sepsis-induced acute lung injury (ALI) is a severe condition with limited effective therapeutics; nicotinamide mononucleotide (NMN) has been reported to exert anti-inflammatory activities.</p></sec><sec><title>Objective</title><p>This study explores the potential mechanisms by which NMN ameliorates sepsis-induced ALI <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>.</p></sec><sec><title>Materials and methods</title><p>Cultured MH-S cells and a murine model were used to evaluate the effect of NMN on sepsis-induced ALI. MH-S cells were stimulated with LPS (1&#x02009;&#x003bc;g/mL) and NMN (500&#x02009;&#x003bc;M) for 12&#x02009;h grouping as control, LPS, and LPS&#x02009;+&#x02009;NMN. Cell viability, apoptotic status, and M1/2 macrophage-related markers were detected. The mice were pretreated intraperitoneally with NMN (500&#x02009;mg/kg) and/or EX-527 (5&#x02009;mg/kg) 1&#x02009;h before LPS injection and randomized into 7 groups (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8): control, LPS, LPS&#x02009;+&#x02009;NMN, NMN, LPS&#x02009;+&#x02009;NMN&#x02009;+&#x02009;EX-527 (a SIRT1 inhibitor), LPS&#x02009;+&#x02009;EX-527, and EX-527. After 12&#x02009;h, lung histopathology, W/D ratio, MPO activity, NAD<sup>+</sup> and ATP levels, M1/2 macrophage-related markers, and expression of the SIRT1/NF-&#x003ba;B pathway were detected.</p></sec><sec><title>Results</title><p>In MH-S cells, NMN significantly decreased the apoptotic rate from 12.25% to 5.74%. In septic mice, NMN improved the typical pathologic findings in lungs and reduced W/D ratio and MPO activity, but increased NAD<sup>+</sup> and ATP levels. Additionally, NMN suppressed M1 but promoted M2 polarization, and upregulated the expression of SIRT1, with inhibition of NF-&#x003ba;B-p65 acetylation and phosphorylation. Furthermore, inhibition of SIRT1 reversed the effects of NMN-induced M2 macrophage polarization.</p></sec><sec><title>Conclusions</title><p>NMN protects against sepsis-induced ALI by promoting M2 macrophage polarization <italic toggle="yes">via</italic> the SIRT1/NF-&#x003ba;B pathway, it might be an effective strategy for preventing or treating sepsis-induced ALI.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>NMN</kwd><kwd>septic lung injury</kwd><kwd>NAD<sup>+</sup></kwd></kwd-group><support-group><funding-group><award-group><funding-source>
<institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>82074153</award-id><award-id>81900041</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>Natural Science Foundation of Tianjin</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100006606</institution-id></institution-wrap>
</funding-source><award-id>20JCYBJC00540</award-id><award-id>20JCZDJC00480</award-id><award-id>21JCYBJC01240</award-id></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China (grant No.82074153 and 81900041); the Natural Science Foundation of Tianjin (grant No. 20JCYBJC00540, 20JCZDJC00480); the Science and Technology Plan Project of Tianjin (grant No. 21JCYBJC01240).</funding-statement></funding-group></support-group><counts><fig-count count="7"/><table-count count="1"/><page-count count="11"/><word-count count="5638"/></counts></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S0001"><title>Introduction</title><p>Sepsis-induced acute lung injury (ALI) is a leading cause of morbidity and mortality worldwide and imposes substantial economic, social, and health burdens (Grasselli et&#x000a0;al. <xref rid="CIT0008" ref-type="bibr">2020</xref>). Despite advances in knowledge of septic pulmonary pathologies over the years, efficient targeted therapies are still lacking (Park et&#x000a0;al. <xref rid="CIT0018" ref-type="bibr">2019</xref>; Xiong et&#x000a0;al. <xref rid="CIT0033" ref-type="bibr">2020</xref>).</p><p>The progression of ALI is largely driven by inflammatory responses, in which macrophages are the predominant effector cells that play a critical role in determining the extent and severity of pulmonary inflammation (Vladimirovna et&#x000a0;al. <xref rid="CIT0028" ref-type="bibr">2016</xref>; Chakraborty et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2017</xref>; Li et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref>). During acute lung injury, macrophages can be activated by various milieu, and the phenotypes exhibit high plasticity to differentiate into classically activated macrophages (M1) and alternatively activated macrophages (M2) (Vladimirovna et&#x000a0;al. <xref rid="CIT0028" ref-type="bibr">2016</xref>). Promoting macrophage transformation towards the M2 phenotype may contribute to inflammatory resolution and tissue repair (Ardura et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2019</xref>). Therefore, inducing M2 polarization may represent a promising therapeutic intervention for sepsis-induced ALI.</p><p>Nicotinamide mononucleotide (NMN) is considered one of the precursors that best represents the biology and therapeutic potential of nicotinamide adenine dinucleotide (NAD<sup>+</sup>) (Zhao et&#x000a0;al. <xref rid="CIT0038" ref-type="bibr">2021</xref>). Evidence indicates that NAD<sup>+</sup> contributes to energy and metabolism homeostasis and mechanisms that affect cell survival in stress and toxicity (Ardura et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2019</xref>). The pharmacological activities in the spotlight of NMN involve cellular biochemical functions, cardio-protection, diabetes, and aging-related complications (Poddar et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2019</xref>). Recently, the roles of NMN in sepsis including reducing cellular inflammation, oxidative stress, and apoptosis has been recognized (Yoshino et&#x000a0;al. <xref rid="CIT0036" ref-type="bibr">2018</xref>; Poddar et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2019</xref>). However, the protective mechanism of NMN remains incompletely understood, and little is known about the effect on macrophage polarization in acute lung injury.</p><p>In addition to cellular bioenergetics and metabolism, NAD<sup>+</sup> plays a crucial role in catalysing deacetylation of sirtuins, which are sensitive to dynamic fluctuations in metabolism (Garc&#x000ed;a-Prat et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2017</xref>; Kane and Sinclair <xref rid="CIT0012" ref-type="bibr">2018</xref>). Sirtuins have been confirmed to be key regulators of sepsis through antioxidant, anti-apoptotic, and anti-inflammatory properties (Covarrubias et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2021</xref>). In this regard, Sirtuin 1 (SIRT1) was recently shown to deacetylate and inactivate transcription factors and coactivators to dampen the inflammatory cascade (Yang et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2021</xref>). The NF-&#x003ba;B pathway plays a central role in regulating the transcription of inflammatory cytokines and mediators during sepsis (Puri and Naura <xref rid="CIT0020" ref-type="bibr">2022</xref>). Herein, we speculated that the SIRT1/NF-&#x003ba;B axis is responsible for the protective effect of NMN against sepsis-induced ALI.</p><p>In the current study, a cultured mouse alveolar macrophage cell line (MH-S) and a murine model of ALI induced by intraperitoneal LPS administration were used to determine the efficacy of NMN and its potential underlying mechanisms. We investigated whether NMN exerts its function in endotoxin-induced ALI by inducing macrophage polarization to M2 phenotype <italic toggle="yes">via</italic> the SIRT1/NF-&#x003ba;B signalling pathway.</p></sec><sec sec-type="materials" disp-level="1" id="S0002"><title>Materials and methods</title><sec disp-level="2" id="S0002-S2001"><title>Cell culture and treatment</title><p>MH-S cells were purchased from Solarbio Science and Technology Co., Ltd. (Beijing, China), an agent of Applied Biosystems. Cell lines were cultured in RPMI-1640 (Gibco, CA, USA) supplemented with 10% foetal bovine serum (Gibco, CA, USA) and 1% penicillin&#x02013;streptomycin solution (Gibco, CA, USA) at 37&#x02009;&#x000b0;C with 5% CO<sub>2</sub>.</p><p>Cells were maintained at approximately 80%&#x02013;90% confluence and seeded at 10<sup>5</sup> cells/mL density in cultured plates. To evaluate the role of NMN in MH-S cells, 1&#x02009;&#x003bc;g/mL LPS (<italic toggle="yes">E. coli</italic>-L2630, Sigma, USA) and/or 125, 250, 500&#x02009;&#x003bc;M NMN (M3501, Sigma, USA) were then added to the plates. After incubation for 12&#x02009;h, adherent cells were collected for further analysis.</p></sec><sec disp-level="2" id="S0002-S2002"><title>Cell viability</title><p>Before being treated with different manipulations, MH-S cells were dissociated and resuspended at a density of 2&#x02009;&#x000d7;&#x02009;10<sup>3</sup> cells/mL, seeded into 96-well plates (100&#x02009;&#x003bc;L each well), and cultured overnight at 37&#x02009;&#x000b0;C. Briefly, 10&#x02009;&#x003bc;L of CCK-8 solution (Beyotime, China) was transferred to microplates and incubated for 2&#x02009;h. Subsequently, cell viability was determined at OD450&#x02009;nm with a microplate reader.</p></sec><sec disp-level="2" id="S0002-S2003"><title>Detection of apoptosis</title><p>The apoptosis of MH-S cells was assessed using an Annexin V-FITC/PI detection kit (Absin, Shanghai, China) following the instruction manual. MH-S cells were collected after dissociation and rinsed with prechilled PBS after 48&#x02009;h in culture. Subsequently, the precipitate was collected in 300&#x02009;&#x003bc;L binding buffer, followed by incubation with Annexin V-FITC (5&#x02009;&#x003bc;L, 15&#x02009;min) and later with PI (5&#x02009;&#x003bc;L, 5&#x02009;min) shielded from light. The intensity was measured using flow cytometry (EXFLOW 206, Dakewe, China) and analysed by FlowJo v10 software (BD Biosciences, USA).</p></sec><sec disp-level="2" id="S0002-S2004"><title>Animals and treatment</title><p>The experiment was approved by the Animal Ethics Committee in the Tianjin Nankai Hospital (Approval No. NKYY-DWLL-2019-012, Tianjin, China). Six-week-old (20&#x02009;&#x0223c;&#x02009;25&#x02009;g) male C57BL/6 mice were supplied by Experimental Animal Technical Co. Ltd. (Beijing, China; animal license number: SYXK (Jing)2017-0024) and maintained in a temperature-controlled facility (humidity: 40%&#x02013;60%, temperature: 22&#x02013;25&#x02009;&#x000b0;C) with a 12-h light/dark cycle. The animals were randomly assigned into seven groups (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8): control, LPS, LPS&#x02009;+&#x02009;NMN, NMN, LPS&#x02009;+&#x02009;NMN&#x02009;+&#x02009;EX-527, LPS&#x02009;+&#x02009;EX-527, and EX-527. To establish the endotoxin-related ALI model, lipopolysaccharide (15&#x02009;mg/kg, Sigma, USA) was injected intraperitoneally as reported previously (Shi et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2021</xref>). Mice were pretreated intraperitoneally with NMN (500&#x02009;mg/kg, Sigma, USA) and/or SIRT1 inhibitor EX-527 (5&#x02009;mg/kg, Beyotime, China) 1&#x02009;h before LPS injection as previously described (Caton et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2011</xref>; Xu et&#x000a0;al. <xref rid="CIT0034" ref-type="bibr">2016</xref>). Additionally, an equal volume of sterile saline served as a vehicle control. The mice were euthanized under deep anaesthesia <italic toggle="yes">via</italic> cervical dislocation after 12&#x02009;h, and care was taken to reduce animal suffering. Serum was obtained by eyeball extirpation with centrifugation at 3000&#x02009;rpm for 10&#x02009;min for further analysis. Lung tissues were fixed in 4% paraformaldehyde or stored at &#x02212;80&#x02009;&#x000b0;C for further analyses.</p></sec><sec disp-level="2" id="S0002-S2005"><title>Lung wet-to-dry weight (W/D) ratio</title><p>The W/D ratio was measured to determine the degree of pulmonary oedema. After determining the wet weight (W), tissues were desiccated at 65&#x02009;&#x000b0;C for 48&#x02009;h to obtain the dry weight (D).</p></sec><sec disp-level="2" id="S0002-S2006"><title>Lung histological analysis</title><p>Histological evaluation of lung tissue was routinely fixed, dehydrated, embedded, and sliced into 4&#x02009;&#x003bc;m thick sections, followed by H&#x00026;E staining. The slices were visualized using a microscope (&#x000d7; 400 magnification, Leica, Germany). Semiquantitative evaluation (lung injury score) of ALI was based on inflammatory cell infiltration, interstitium widening, oedema, and haemorrhage (Li et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref>; Shi et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2021</xref>). Each characteristic was scored (0: normal to 4: very severe) by a pathologist blinded to the experimental setup.</p></sec><sec disp-level="2" id="S0002-S2007"><title>NAD<sup>+</sup> and NAD<sup>+</sup>/NADH measurement</title><p>NAD<sup>+</sup> concentrations from the lungs were measured with an NAD/NADH Assay Kit (KA1657, Abnova, China) according to the manufacturer&#x02019;s protocols. For sample preparation, frozen lung tissue (20&#x02009;mg) was homogenized and 100&#x02009;&#x003bc;L NAD and NADH extraction buffer were added for NAD and NADH detection, respectively. The extracts were heated for 5&#x02009;min at 60&#x02009;&#x000b0;C, followed by 20&#x02009;&#x003bc;L assay buffer and 100&#x02009;&#x003bc;L negative buffer to centrifugated at 14000&#x02009;rpm for 5&#x02009;min, the supernatant was collected and used for detection of NAD and NADH levels. Subsequently, 61&#x02009;&#x003bc;L assay buffer, 12&#x02009;&#x003bc;L MTT, 1&#x02009;&#x003bc;L NAD cycling enzyme mix, and 1&#x02009;&#x003bc;L PES were mixed as working reagents, and 40&#x02009;&#x003bc;L sample and 80&#x02009;&#x003bc;L working reagent were added per well. The absorbance was measured at 565&#x02009;nm, and the NAD<sup>+</sup> concentration was calculated as the total NAD content minus the NADH content.</p></sec><sec disp-level="2" id="S0002-S2008"><title>ATP content</title><p>Pre-weighted lung tissue was processed for measurement of lung ATP content using a commercial kit (Beyotime, China). This ATP assay kit is based on the quantitative measurement of a stable level of light by luciferase-catalyzed enzymatic reactions. Approximately 20&#x02009;mg of lung tissue was homogenized in 200&#x02009;mL lysates and centrifuged at 12000&#x02009;<italic toggle="yes">g</italic> for 5&#x02009;min. The supernatant was added to 100&#x02009;&#x003bc;L ATP assay buffer and then the ATP concentrations were calculated from the standard curve data and normalized to the corresponding tissue weight.</p></sec><sec disp-level="2" id="S0002-S2009"><title>Assessment of myeloperoxidase (MPO) activity</title><p>MPO activity from lung tissue was measured by an MPO detection kit (A044-1-1, Nanjing Jiancheng, China) following the instructions. Briefly, lung tissues were homogenized and the supernatant was incubated with the reaction buffer in a water bath at 60&#x02009;&#x000b0;C for 10&#x02009;min, then the OD 460&#x02009;nm was evaluated by a spectrophotometer (Lambda 35, PerkinElmer, USA). The activities of MPO are presented as U/g of tissue.</p></sec><sec disp-level="2" id="S0002-S2010"><title>Flow cytometry analysis</title><p>MH-S cells and single-cell lung suspensions were prepared as previously described (Deng et&#x000a0;al. <xref rid="CIT0005" ref-type="bibr">2020</xref>). Thereafter, all single cells were resuspended in staining buffer (BD Bioscience, San Diego, CA, USA) and then stained with the following monoclonal antibodies: PE-F4/80 antibody (cat. 565410, BD, USA), FITC-CD11b antibody (cat. 557396, BD, USA), APC-CD86 antibody (cat. 558703, BD, USA), and PerCP-CD206 antibody (cat. 141716, BD, USA). All single cells were incubated with antibodies in the dark for 15&#x02009;min and washed with PBS. Data were collected using EXFLOW 206 (Dakewe, China) and analysed using FlowJo v10 software (BD, USA).</p></sec><sec disp-level="2" id="S0002-S2011"><title>Reverse-transcription polymerase chain reaction (RT-PCR)</title><p>Total RNA from the lungs was isolated by a Qiagen RNeasy kit (Hilden, Germany) and cDNA was performed with a cDNA synthesis kit (TaKaRa, China). The reverse transcription conditions were 37&#x02009;&#x000b0;C for 15&#x02009;min, 85&#x02009;&#x000b0;C for 5&#x02009;s, followed by 4&#x02009;&#x000b0;C for 10&#x02009;min (T100 Thermal Cycler, Bio-Rad, USA). The amplification conditions were 30&#x02009;s at 95&#x02009;&#x000b0;C for pre-denaturation, 5&#x02009;s at 95&#x02009;&#x000b0;C for 40 cycles of denaturation, 5&#x02009;s at 95&#x02009;&#x000b0;C for annealing and 34&#x02009;s at 60&#x02009;&#x000b0;C for extension (7500 real-time PCR system, Applied Biosystems, USA). Data were calculated through 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method and the primers are listed in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="t0001"><label>Table 1.</label><caption><p>Primer sequences for RT-PCR.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th align="left">Genes</th><th align="center">Forward sequence (5&#x02019;-3&#x02019;)</th><th align="center">Reverse sequence (5&#x02019;-3&#x02019;)</th></tr></thead><tbody valign="top"><tr><td align="left">GAPDH</td><td align="left">CCTGGAGAAACCTGCCAAGTA</td><td align="left">GGAAGAGTGGGAGTTGCTGTTG</td></tr><tr><td align="left">TNF-&#x003b1;</td><td align="left">GGCAGGTCTACTTTGGAGTCATTGC</td><td align="left">ACATTCGAGGCTCCAGTGAATTCGG</td></tr><tr><td align="left">IL-10</td><td align="left">ACCTGGTAGAAGTGATGCCCCAGGCA</td><td align="left">CTATGCAGTTGATGAAGATGTCAAA</td></tr><tr><td align="left">IL-6</td><td align="left">CCACTGCCTTCCCTACTTCA</td><td align="left">TCTTGGTCCTTAGCCACTCC</td></tr><tr><td align="left">IL-1&#x003b2;</td><td align="left">GCTGCTTCCAAACCTTTGAC</td><td align="left">AGCTTCTCCACAGCCACAAT</td></tr><tr><td align="left">Arg1</td><td align="left">AACACGGCAGTGGCTTTAACCT</td><td align="left">GTGATGCCCCAGATGGTTTTC</td></tr><tr><td align="left">iNOS</td><td align="left">AGGAAGTGGGCCGAAGGAT</td><td align="left">GAAACTATGGAGCACAGCCACAT</td></tr></tbody></table></table-wrap></sec><sec disp-level="2" id="S0002-S2012"><title>Immunofluorescence</title><p>Lung slices were prepared as described above and incubated with anti-AceNF-&#x003ba;B-p65 (1:200, Thermo Fisher Scientific, PA5-114696, USA) primary antibody for 12&#x02009;h at 4&#x02009;&#x000b0;C and secondary antibody (1:200, Beyotime, China) for 1&#x02009;h. Nuclear counterstaining was stained with 4&#x02032;-6-diamidino-2-phenylindole (DAPI), followed by visualization with a Leica DM4000B microscope. Finally, the proportion of positive protein was calculated using ImageJ software.</p></sec><sec disp-level="2" id="S0002-S2013"><title>Western blot</title><p>Total protein was isolated using a total protein isolation kit (Solarbio, China) and its concentrations were estimated with the BCA method (Solarbio, China). Proteins (30&#x02009;&#x003bc;g/per well) were applied for electrophoresis (5%&#x0223c;10% SDS-PAGE) and then transferred onto polyvinylidene difluoride membranes (0.2&#x02009;&#x000b5;M, Bio-Rad, USA). Subsequently, the PVDF membrane was blocked for 1.5&#x02009;h at room temperature and then incubated with primary antibodies against iNOS (1:1000, ab178945), Arg1 (1:1000, CST93668), SIRT1 (1:1000, ab189494), acetyl-NF-&#x003ba;B p65 (Lys310) (1:1000, CST3045), phospho-NF-&#x003ba;B p65 (Ser536) (1:1000, CST3033), NF-&#x003ba;B-p65 (1:1000, CST8242), &#x003b2;-actin (1:2000, ab8226) overnight at 4&#x02009;&#x000b0;C, and then incubated with secondary antibodies (1:3000, CST7074) for 1&#x02009;h. Enhanced chemiluminescence (170-5070, Bio-Rad, USA) was applied for blots developing and the density was calculated by ImageJ system.</p></sec><sec disp-level="2" id="S0002-S2014"><title>Statistical analysis</title><p>Values were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD and were analysed by one-way ANOVA followed by the Bonferroni <italic toggle="yes">post hoc</italic> test by Graph Pad Prime 8.0 (La Jolla, USA). <italic toggle="yes">P</italic> value &#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" disp-level="1" id="S0003"><title>Results</title><sec disp-level="2" id="S0003-S2001"><title>NMN improved cell viability and apoptosis status of LPS-treated MH-S cells</title><p>To assess the potential cytotoxicity of NMN and its pretreatment on the LPS-treated MH-S cells, cellular viability was determined. The results suggested that the proliferative capacity of MH-S cells was unaffected by NMN at concentrations between 125 and 500&#x02009;&#x003bc;M. Significantly decreased cell viability was observed after LPS stimulation, but when 500&#x02009;&#x003bc;M NMN was incubated in the LPS group, there was a marked improvement in cell viability. In the settings, a dose of 500&#x02009;&#x003bc;M NMN was used for the subsequent experiments <italic toggle="yes">in vitro</italic> (<xref rid="F0001" ref-type="fig">Figure 1(A)</xref>).</p><fig position="float" id="F0001"><label>Figure 1.</label><caption><p>Effect of NMN on cell proliferation and apoptosis of LPS-stimulated MH-S lines. (A) Cell viability of differentially treated MH-S cells was determined by CCK8 kit. (B&#x02013;C) Apoptosis of MH-S cells induced by different groups as indicated was measured by Annexin V-FITC/PI. Data are portrayed as mean&#x02009;&#x000b1;&#x02009;SD and statistical analysis was performed by one-way ANOVA followed by the Bonferroni <italic toggle="yes">post hoc</italic> test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. controls, <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. LPS group.</p></caption><graphic xlink:href="IPHB_A_2292256_F0001_C" content-type="color" position="float"/></fig><p>Apoptosis represents a critical feature of acute lung injury. LPS stimulation increased the apoptotic rate to 12.25%, but apoptosis was greatly alleviated by NMN treatment, leading to a significantly decreased apoptotic rate to 5.74% (<xref rid="F0001" ref-type="fig">Figure 1(B,C)</xref>).</p></sec><sec disp-level="2" id="S0003-S2002"><title>NMN regulated macrophage polarization from M1 to M2 phenotype in LPS-treated MH-S cells</title><p>Mounting studies point to a critical role of macrophage polarization in the development of sepsis and sepsis-induced organ injury. We thus measured the expression of inflammatory mediators and macrophage polarization related biomarkers. RT-PCR and immunoblotting analysis showed that administration of NMN prevented the LPS-induced M1 phenotype marker expression (pro-inflammatory cytokine IL-1&#x003b2;, TNF-&#x003b1;, IL-6, and iNOS) (<xref rid="F0002" ref-type="fig">Figure 2(A,B,D</xref>, E)), but elevated the M2 phenotype related markers (anti-inflammatory mediators IL-10 and Arg1) (<xref rid="F0002" ref-type="fig">Figure 2(A,C,D,F)</xref>). These results suggest that NMN incubation could polarize macrophages to an M2-like phenotype.</p><fig position="float" id="F0002"><label>Figure 2.</label><caption><p>NMN promotes M2-type macrophage polarization in LPS-stimulated MH-S cells. (A) Relative mRNA expressions of IL-1&#x003b2;, TNF-&#x003b1;, IL-6 and IL-10 were detected. (B) Representative mRNA levels of iNOS. (C) Representative mRNA levels of Arg1. (D&#x02013;F) Representative blots and relative expressions of iNOS and Arg1 in MH-S cells. Data are presented as mean&#x02009;&#x000b1;&#x02009;SD and analysed by one-way ANOVA corrected with Bonferroni test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 relative to controls, <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 relative to LPS group, respectively.</p></caption><graphic xlink:href="IPHB_A_2292256_F0002_B" content-type="black-white" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2003"><title>NMN alleviated endotoxin-induced acute lung injury in mice</title><p>To observe the effect of NMN on endotoxin-induced ALI, NMN (500&#x02009;mg/kg, i.p.) was administered 1&#x02009;h prior to LPS injection. Photomicrographs in the LPS group revealed explicit pathological alterations, including thickened alveolar wall, inflammatory cell infiltration, septa swelling, and erythrocyte exudation, which were dramatically ameliorated in the LPS&#x02009;+&#x02009;NMN group (<xref rid="F0003" ref-type="fig">Figure 3(A)</xref>). Consistently, semiquantitative lung injury scores showed that NMN pretreatment significantly decreased the scores relative to mice subjected to LPS (<xref rid="F0003" ref-type="fig">Figure 3(B)</xref>). In addition, the W/D ratio and MPO activity were also detected as indicators of lung oedema and neutrophil accumulation, respectively. Septic mice showed a noticeably higher W/D ratio and MPO activity relative to controls, while NMN administration suppressed the degree of pulmonary oedema and neutrophil recruitment (<xref rid="F0003" ref-type="fig">Figure 3(C,D)</xref>).</p><fig position="float" id="F0003"><label>Figure 3.</label><caption><p>NMN attenuates lung injury induced by LPS. (A) The image of histopathologic changes of lung sections with H&#x00026;E staining (&#x000d7;400). (B) Semiquantitative assessment of ALI using lung injury scores. The grading scale of 0&#x02009;=&#x02009;minimal damage, 1+ =mild damage (25%), 2+ =moderate damage (50%), 3+ =severe damage (75%), and 4+ =maximal damage (almost 100%). (C) The W/D ratio. (D) MPO activity. Data are presented as mean&#x02009;&#x000b1;&#x02009;SD and analysed by one-way ANOVA followed with Bonferroni test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. control and <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. LPS group.</p></caption><graphic xlink:href="IPHB_A_2292256_F0003_C" content-type="color" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2004"><title>NMN increased NAD<sup>+</sup> and preserved bioenergetics</title><p>Sepsis results in considerably fluctuating pyridine and adenine nucleotide pools, even depleted ATP reserves, which negatively affect the function of vital organs (Wei et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2021</xref>). Thus, we evaluated whether exogenous NMN could maintain NAD<sup>+</sup> and ATP levels in lung tissues during endotoxin-induced ALI. Compared with controls, NMN significantly elevated NAD<sup>+</sup>, NAD<sup>+</sup>/NADH ratio, and ATP levels (<xref rid="F0004" ref-type="fig">Figure 4(A&#x02013;C)</xref>). LPS caused a defensive increase in NAD<sup>+</sup> levels but decreased NAD<sup>+</sup>/NADH ratio and ATP levels (<xref rid="F0004" ref-type="fig">Figure 4(A&#x02013;C)</xref>). Notably, pretreatment with NMN markedly upregulated NAD<sup>+</sup>, NAD<sup>+</sup>/NADH ratio, and ATP levels, indicating that NMN increased NAD<sup>+</sup> levels and restored ATP levels following LPS-induced ALI (<xref rid="F0004" ref-type="fig">Figure 4(A&#x02013;C)</xref>).</p><fig position="float" id="F0004"><label>Figure 4.</label><caption><p>The impact of NMN on NAD<sup>+</sup> and ATP levels in lung tissues. (A) The levels of NAD<sup>+</sup> were determined with an NAD/NADH Assay Kit. (B) NAD<sup>+</sup>/NADH ratio in lung tissues. (<bold>C</bold>) ATP content was also detected in this part of the study. Data are expressed as mean&#x02009;&#x000b1;&#x02009;SD using one-way ANOVA followed with Bonferroni test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. control and <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. LPS group.</p></caption><graphic xlink:href="IPHB_A_2292256_F0004_B" content-type="black-white" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2005"><title>NMN polarized macrophages toward M2 anti-inflammatory profile in LPS-induced ALI</title><p>Based on the above observations, we next evaluated the impact of NMN on macrophage polarization and found that the levels of M1 macrophage-specific genes (IL-1&#x003b2;, TNF-&#x003b1;, and IL-6) were downregulated and the M2 macrophage-specific genes (IL-10) were upregulated in septic mice treated with NMN (<xref rid="F0005" ref-type="fig">Figure 5(A)</xref>). Apart from inflammatory mediators, NMN suppressed the increase in the expression of M1-related biomarker iNOS induced by LPS but promoted the expression of the M2-related biomarker Arg1 (<xref rid="F0005" ref-type="fig">Figure 5(B&#x02013;D)</xref>).</p><fig position="float" id="F0005"><label>Figure 5.</label><caption><p>Effect of NMN on macrophage differentiation during LPS-induced ALI. (A) Relative mRNA levels of inflammatory cytokines IL-1&#x003b2;, TNF-&#x003b1;, IL-6, and IL-10 were determined. (B&#x02013;D) Western blots of iNOS and Arg1 and quantitation. (E&#x02013;G) The levels of CD86 (for M1 macrophages) and CD206 (for M2 macrophages) were evaluated by flow cytometric analysis. Values are expressed as mean&#x02009;&#x000b1;&#x02009;SD and analysed by one-way ANOVA corrected with Bonferroni coefficient. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. control group and <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. LPS group, respectively.</p></caption><graphic xlink:href="IPHB_A_2292256_F0005_C" content-type="color" position="float"/></fig><p>Pulmonary macrophages were labelled as CD11b and F4/80 double-positive cells, in which CD86 and CD206 served as markers of M1 and M2 macrophages, respectively. Flow cytometric analysis intuitively indicated that NMN administration induced a highly pronounced anti-inflammatory M2 phenotype (CD206<sup>+</sup> F4/80<sup>+</sup>) when mice were subjected to LPS while inhibiting the pro-inflammatory M1 phenotype (CD86<sup>+</sup> F4/80<sup>+</sup>) (<xref rid="F0005" ref-type="fig">Figure 5(E&#x02013;G)</xref>).</p></sec><sec disp-level="2" id="S0003-S2006"><title>NMN activated the SIRT1/NF-&#x003ba;B pathway in septic lung tissue</title><p>To observe whether NMN alleviated ALI through the SIRT1/NF-&#x003ba;B pathway. First, immunoblotting showed that SIRT1 expression was significantly increased by LPS stimulation, which was consistent with the change in NAD<sup>+</sup> levels (<xref rid="F0006" ref-type="fig">Figure 6(A,B)</xref>). Exogenous NMN upregulated SIRT1 protein levels with or without LPS treatment. As expected, immunoblotting and immunofluorescence showed that acetylated NF-&#x003ba;B-p65 was upregulated in septic mice, while NMN repressed acetylation (<xref rid="F0006" ref-type="fig">Figure 6(A,C,F,G)</xref>). Moreover, we also assessed the phosphorylation of NF-&#x003ba;B-p65, a critical proinflammatory pathway protein in alveolar macrophages and a sign of NF-&#x003ba;B activation. The results showed that NMN markedly suppressed the phosphorylation of NF-&#x003ba;B-p65 (<xref rid="F0006" ref-type="fig">Figure 6(A,D)</xref>). These findings strongly suggested that NMN acted <italic toggle="yes">via</italic> the SIRT1/NF-&#x003ba;B pathway to mitigate septic lung injury.</p><fig position="float" id="F0006"><label>Figure 6.</label><caption><p>NMN activated the SIRT1/NF-&#x003ba;B pathway in sepsis-related ALI. (A&#x02013;E) Representative bands and quantification of SIRT1, acetylated, phosphorylated NF-&#x003ba;B-p65, and NF-&#x003ba;B-p65. (F&#x02013;G) Levels of acetylated NF-&#x003ba;B-p65 were shown by immunofluorescence (scale bar = 50&#x02009;&#x003bc;m). Data are presented as means&#x02009;&#x000b1;&#x02009;SD and analysed by one-way ANOVA followed with Bonferroni coefficient. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared with control; <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared with LPS group.</p></caption><graphic xlink:href="IPHB_A_2292256_F0006_C" content-type="color" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2007"><title>The SIRT1/NF-&#x003ba;B signalling pathway was involved in NMN-mediated M2 macrophage polarization <italic toggle="yes">in vivo</italic></title><p>To further determine whether SIRT1/NF-&#x003ba;B signaling activation was associated with NMN-regulated macrophage polarization, we examined the effect of SIRT1 inhibitor EX-527 on markers of M1/2 phenotype. As shown in <xref rid="F0007" ref-type="fig">Figure 7</xref>, EX-527 treatment decreased the expression of SIRT1, and enhanced expression of acetylated and phosphorylated NF-&#x003ba;B-p65 in septic mice pretreated with NMN (<xref rid="F0007" ref-type="fig">Figure 7(A&#x02013;D)</xref>). In addition, SIRT1 inhibitor EX-527 also significantly promoted the expression of M1 macrophage-associated markers (iNOS and CD86) while inhibiting M2 phenotype expression (Arg1 and CD206) (<xref rid="F0007" ref-type="fig">Figure 7(A,F&#x02013;J)</xref>). These results indicated that inhibition of SIRT1/NF-&#x003ba;B signaling reversed NMN-mediated M2 macrophage polarization.</p><fig position="float" id="F0007"><label>Figure 7.</label><caption><p>The SIRT1/NF-&#x003ba;B pathway was associated with the NMN-mediated M2 macrophage polarization. (A&#x02013;G) Representative bands and quantification of SIRT1, acetylated, phosphorylated NF-&#x003ba;B-p65, NF-&#x003ba;B-p65, iNOS, and Arg1. (H&#x02013;J) The levels of CD86 (for M1 macrophages) and CD206 (for M2 macrophages) were evaluated by flow cytometric analysis. Data are presented as means&#x02009;&#x000b1;&#x02009;SD and analysed by one-way ANOVA followed with Bonferroni coefficient. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared with control; <sup>#</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared with LPS group.</p></caption><graphic xlink:href="IPHB_A_2292256_F0007_C" content-type="color" position="float"/></fig></sec></sec><sec sec-type="discussion" disp-level="1" id="S0004"><title>Discussion</title><p>Although the pathogenesis and potential therapies of endotoxin-induced ALI have been extensively recognized, optimal strategies to improve the resolution of inflammation and outcomes of patients remain to be determined. The present study demonstrated that NMN, an NAD<sup>+</sup> precursor, exerted a potent anti-inflammatory effect and bioenergetic preservation. Additionally, NMN efficiently inhibited M1 macrophage polarization but promoted M2 polarization, and NMN targeted and regulated SIRT1/NF-&#x003ba;B signalling pathways thereby inhibiting the activation of NF-&#x003ba;B signaling and reducing inflammatory cascade. We further confirmed the beneficial pharmacological intervention of NMN on macrophage phenotype switching toward M2 <italic toggle="yes">via</italic> the SIRT1/NF-&#x003ba;B pathway.</p><p>NAD<sup>+</sup> is a vital cofactor for multiple metabolic reactions that tightly impact mitochondrial bioenergetic metabolism and capacity, and accumulated studies have focused on the properties of DNA repair, anti-aging, and anti-inflammation (Rajman et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2018</xref>; Covarrubias et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2021</xref>; Navas and Carnero <xref rid="CIT0017" ref-type="bibr">2021</xref>; He et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2022</xref>). Notably, it has been demonstrated that the NAD<sup>+</sup>-related metabolite NMN could decrease the susceptibility to inflammatory disease and reduce oxidative stress (Guan et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2017</xref>; Wan et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2021</xref>; Zhang et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2021</xref>). Thus, further investigation will be required to identify the efficacy and detailed mechanisms of NMN in sepsis-induced ALI. Here, we observed that NMN could reduce the apoptosis and production of pro-inflammatory factor in LPS-stimulated MH-S cells and ameliorates pathologic lung injury in a murine septic model. NAD<sup>+</sup> fluctuations and ATP depletion contribute to hallmarks of and driving forces behind sepsis (Suntharalingam et&#x000a0;al. <xref rid="CIT0026" ref-type="bibr">2015</xref>; Hopp et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">2021</xref>). NMN administration significantly upregulated NAD<sup>+</sup> and ATP contents for maintaining mitochondrial function and cellular homeostasis. Collectively, our results identified the pivotal role of NMN in attenuating LPS-induced lung injury.</p><p>Macrophage polarization plays a prominent role in sepsis (Gong et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2019</xref>). M1 macrophages are characterized by secreting pro-inflammatory cytokines (TNF-&#x003b1;, IL-1&#x003b2;, and IL-6) and expressing hallmarks iNOS and CD86, then surge and amplify the &#x0201c;cytokine storm&#x0201d;, leading to organ damage (Wu et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2021</xref>). The M2 phenotype can produce anti-inflammatory factors (IL-10) and is labelled by specific markers CD206 and Arg1, which can resolve inflammation, promote wound healing, and suppress immunity (Wang et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2013</xref>). In this study, we found that the levels of pro-inflammatory cytokines and M1 markers robustly increased after LPS treatment. Conversely, NMN administration effectively inhibited the expression of M1-related markers and upregulated M2-related markers in response to LPS <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>.</p><p>Compelling evidence indicates that SIRT1 is a crucial dominator in the pathologies of sepsis as SIRT1 confers lung protection by inhibiting inflammation, apoptosis, oxidative stress, and fibrosis through the deacetylation of transcription factors and coactivators (Raji-Amirhasani et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2021</xref>). As NF-&#x003ba;B is a critical regulator of immune function, SIRT1/NF-&#x003ba;B signaling represents one of the critical cytoprotective mechanisms against various pathophysiological processes such as ulcerative colitis, neurological disorders, liver fibrosis, and sepsis (Liu et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2020</xref>; Shi et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2021</xref>; Shin et&#x000a0;al. <xref rid="CIT0025" ref-type="bibr">2021</xref>; Tang et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2021</xref>). Notably, an obvious upregulation of SIRT1 protein was found in the LPS group contradictory to other studies (Mohamed et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2021</xref>), the defensive action which may be related to the dose and timing of LPS stimulation. Importantly, acetylated NF-&#x003ba;B-p65 was significantly increased under LPS stimulation, also the phosphorylated form of p65 was elevated, suggesting that NF-&#x003ba;B signalling was completely activated. However, NMN pretreatment increased the expression of SIRT1 but reduced the acetylation and phosphorylation of NF-&#x003ba;B-p65, suggesting that SIRT1/NF-&#x003ba;B signalling pathway might be involved in the lung protection of NMN. Furthermore, we found that EX-527 (a SIRT1 inhibitor) suppressed M2 polarization and exaggerated M1 polarization, which reversed the effect of NMN on macrophage phenotype. Therefore, we further confirmed that NMN promotes M2-like polarization by activating the SIRT1/NF-&#x003ba;B signaling pathway.</p><p>The current study has certain limitations. A plethora of evidence has demonstrated that substrates for SIRT1 deacetylase activity which include but are not limit to NF-&#x003ba;B-p65, deacetylation of p53, PGC1&#x003b1;, and FoxO, which are equally important for the resolution of inflammation. Thus, the underlying mechanism by which NMN attenuates ALI remains unclear and requires a more comprehensive study.</p></sec><sec sec-type="conclusions" disp-level="1" id="S0005"><title>Conclusions</title><p>NMN can effectively ameliorate sepsis-induced ALI through modulating macrophage polarization <italic toggle="yes">via</italic> SIRT1/NF-&#x003ba;B signalling pathway, which may provide a novel therapeutic direction for treating acute lung injury.</p></sec></body><back><sec disp-level="1" id="S0006"><title>Authors&#x02019; contributions</title><p>SMH and JBY conceived and designed the experiments, the experiments in MH-S cells were performed by XHJ, XYW and SHD, and experiments in animal models were performed by SMH, JY, and SAD. Experimental analysis was performed by YW, JS, YZ and LRG; the first draft of the manuscript was written by SMH and all authors commented on previous versions of the manuscript; all authors read and approved the final manuscript.</p></sec><sec sec-type="COI-statement" disp-level="1" id="S0007"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ardura</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Rackov</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Izquierdo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Alonso</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gortazar</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Escribese</surname>
<given-names>MM.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Targeting macrophages: friends or foes in disease?</article-title>
<source>Front Pharmacol</source>. <volume>10</volume>:<fpage>1255</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2019.01255</pub-id>.<pub-id pub-id-type="pmid">31708781</pub-id>
</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Caton</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Kieswich</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yaqoob</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Holness</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Sugden</surname>
<given-names>MC.</given-names></string-name></person-group>
<year>2011</year>. <article-title>Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function</article-title>. <source>Diabetologia</source>. <volume>54</volume>(<issue>12</issue>):<fpage>3083</fpage>&#x02013;<lpage>3092</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00125-011-2288-0</pub-id>.<pub-id pub-id-type="pmid">21901281</pub-id>
</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chakraborty</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Raundhal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>Morse</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tyurina</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Khare</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Oriss</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Huff</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>St Croix</surname>
<given-names>CM</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2017</year>. <article-title>The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia</article-title>. <source>Nat Commun</source>. <volume>8</volume>(<issue>1</issue>):<fpage>13944</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms13944</pub-id>.<pub-id pub-id-type="pmid">28074841</pub-id>
</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Covarrubias</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Perrone</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Grozio</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Verdin</surname>
<given-names>E.</given-names></string-name></person-group>
<year>2021</year>. <article-title>NAD<sup>+</sup> metabolism and its roles in cellular processes during ageing</article-title>. <source>Nat Rev Mol Cell Biol</source>. <volume>22</volume>(<issue>2</issue>):<fpage>119</fpage>&#x02013;<lpage>141</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-020-00313-x</pub-id>.<pub-id pub-id-type="pmid">33353981</pub-id>
</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>X</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2020</year>. <article-title>Bone marrow mesenchymal stem cell-derived exosomes attenuate LPS-induced ARDS by modulating macrophage polarization through inhibiting glycolysis in macrophages</article-title>. <source>Shock</source>. <volume>54</volume>(<issue>6</issue>):<fpage>828</fpage>&#x02013;<lpage>843</lpage>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000001549</pub-id>.<pub-id pub-id-type="pmid">32433208</pub-id>
</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garc&#x000ed;a-Prat</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sousa-Victor</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mu&#x000f1;oz-C&#x000e1;noves</surname>
<given-names>P.</given-names></string-name></person-group>
<year>2017</year>. <article-title>Proteostatic and metabolic control of stemness</article-title>. <source>Cell Stem Cell</source>. <volume>20</volume>(<issue>5</issue>):<fpage>593</fpage>&#x02013;<lpage>608</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.stem.2017.04.011</pub-id>.<pub-id pub-id-type="pmid">28475885</pub-id>
</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>H</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2019</year>. <article-title>Intestinal microbiota mediates the susceptibility to polymicrobial sepsis-induced liver injury by granisetron generation in mice</article-title>. <source>Hepatology</source>. <volume>69</volume>(<issue>4</issue>):<fpage>1751</fpage>&#x02013;<lpage>1767</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep.30361</pub-id>.<pub-id pub-id-type="pmid">30506577</pub-id>
</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grasselli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tonetti</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Protti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Langer</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Girardis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bellani</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Laffey</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Carrafiello</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Carsana</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rizzuto</surname>
<given-names>C</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2020</year>. <article-title>Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study</article-title>. <source>Lancet Respir Med</source>. <volume>8</volume>(<issue>12</issue>):<fpage>1201</fpage>&#x02013;<lpage>1208</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2213-2600(20)30370-2</pub-id>.<pub-id pub-id-type="pmid">32861276</pub-id>
</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>XZ</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>QH</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Shang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hao</surname>
<given-names>CM.</given-names></string-name></person-group>
<year>2017</year>. <article-title>Nicotinamide mononucleotide, an NAD<sup>+</sup> precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner</article-title>. <source>J Am Soc Nephrol</source>. <volume>28</volume>(<issue>8</issue>):<fpage>2337</fpage>&#x02013;<lpage>2352</lpage>. doi: <pub-id pub-id-type="doi">10.1681/ASN.2016040385</pub-id>.<pub-id pub-id-type="pmid">28246130</pub-id>
</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>J.</given-names></string-name></person-group>
<year>2022</year>. <article-title>NAD<sup>+</sup> ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3&#x003b2;/Nrf2 signalling pathway</article-title>. <source>J Cell Mol Med</source>. <volume>26</volume>(<issue>7</issue>):<fpage>1979</fpage>&#x02013;<lpage>1993</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.17222</pub-id>.<pub-id pub-id-type="pmid">35137552</pub-id>
</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hopp</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Teloni</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bisceglie</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gondrand</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Raith</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Nowak</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Muskalla</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Howald</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pedrioli</surname>
<given-names>PGA</given-names></string-name>, <string-name><surname>Johnsson</surname>
<given-names>K</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2021</year>. <article-title>Mitochondrial NAD<sup>+</sup> controls nuclear ARTD1-induced ADP-ribosylation</article-title>. <source>Mol Cell</source>. <volume>81</volume>(<issue>2</issue>):<fpage>340</fpage>&#x02013;<lpage>354.e345</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2020.12.034</pub-id>.<pub-id pub-id-type="pmid">33450210</pub-id>
</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kane</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Sinclair</surname>
<given-names>DA.</given-names></string-name></person-group>
<year>2018</year>. <article-title>Sirtuins and NAD<sup>+</sup> in the development and treatment of metabolic and cardiovascular diseases</article-title>. <source>Circ Res</source>. <volume>123</volume>(<issue>7</issue>):<fpage>868</fpage>&#x02013;<lpage>885</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.312498</pub-id>.<pub-id pub-id-type="pmid">30355082</pub-id>
</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>JQ</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>ZH</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Q.</given-names></string-name></person-group>
<year>2021</year>. <article-title>LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway: XIST promotes ALI via miR-132-3p/MAPK14 axis</article-title>. <source>Mol Cell Biochem</source>. <volume>476</volume>(<issue>12</issue>):<fpage>4217</fpage>&#x02013;<lpage>4229</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11010-021-04234-x</pub-id>.<pub-id pub-id-type="pmid">34346000</pub-id>
</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Heme oxygenase-1(HO-1) regulates Golgi stress and attenuates endotoxin-induced acute lung injury through hypoxia inducible factor-1&#x003b1; (HIF-1&#x003b1;)/HO-1 signaling pathway</article-title>. <source>Free Radic Biol Med</source>. <volume>165</volume>:<fpage>243</fpage>&#x02013;<lpage>253</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.01.028</pub-id>.<pub-id pub-id-type="pmid">33493554</pub-id>
</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Bao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>J.</given-names></string-name></person-group>
<year>2020</year>. <article-title>Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-&#x003ba;B signaling pathway to attenuate ulcerative colitis</article-title>. <source>Bioengineered</source>. <volume>11</volume>(<issue>1</issue>):<fpage>628</fpage>&#x02013;<lpage>639</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21655979.2020.1774992</pub-id>.<pub-id pub-id-type="pmid">33034242</pub-id>
</mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohamed</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Ibrahim</surname>
<given-names>SRM</given-names></string-name>, <string-name><surname>El-Agamy</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Elsaed</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Sirwi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Asfour</surname>
<given-names>HZ</given-names></string-name>, <string-name><surname>Koshak</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Elhady</surname>
<given-names>SS.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Terretonin as a new protective agent against sepsis-induced acute lung injury: impact on SIRT1/Nrf2/NF-&#x003ba;Bp65/NLRP3 signaling</article-title>. <source>Biology (Basel)</source>. <volume>10</volume>(<issue>11</issue>):<fpage>1219</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology10111219</pub-id>.<pub-id pub-id-type="pmid">34827212</pub-id>
</mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Navas</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Carnero</surname>
<given-names>A.</given-names></string-name></person-group>
<year>2021</year>. <article-title>NAD<sup>+</sup> metabolism, stemness, the immune response, and cancer</article-title>. <source>Signal Transduct Target Ther</source>. <volume>6</volume>(<issue>1</issue>):<fpage>2</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-020-00354-w</pub-id>.<pub-id pub-id-type="pmid">33384409</pub-id>
</mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Choe</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ahn</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Jo</surname>
<given-names>YH</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2019</year>. <article-title>Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury</article-title>. <source>Eur Respir J</source>. <volume>53</volume>(<issue>3</issue>):<fpage>1800786</fpage>. doi: <pub-id pub-id-type="doi">10.1183/13993003.00786-2018</pub-id>.<pub-id pub-id-type="pmid">30635296</pub-id>
</mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poddar</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Sifat</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Haque</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nahid</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Chowdhury</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mehedi</surname>
<given-names>I.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule</article-title>. <source>Biomolecules</source>. <volume>9</volume>(<issue>1</issue>):<fpage>34</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom9010034</pub-id>.<pub-id pub-id-type="pmid">30669679</pub-id>
</mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Puri</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Naura</surname>
<given-names>AS.</given-names></string-name></person-group>
<year>2022</year>. <article-title>Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice</article-title>. <source>Free Radic Res</source>. <volume>56</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10715762.2021.2023740</pub-id>.<pub-id pub-id-type="pmid">35129032</pub-id>
</mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Raji-Amirhasani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khaksari</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Darvishzadeh Mahani</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hajializadeh</surname>
<given-names>Z.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury)</article-title>. <source>Clin Exp Nephrol</source>. <volume>25</volume>(<issue>8</issue>):<fpage>807</fpage>&#x02013;<lpage>821</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10157-021-02057-0</pub-id>.<pub-id pub-id-type="pmid">33779856</pub-id>
</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rajman</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chwalek</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sinclair</surname>
<given-names>DA.</given-names></string-name></person-group>
<year>2018</year>. <article-title>Therapeutic potential of NAD-boosting molecules: the in vivo evidence</article-title>. <source>Cell Metab</source>. <volume>27</volume>(<issue>3</issue>):<fpage>529</fpage>&#x02013;<lpage>547</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.011</pub-id>.<pub-id pub-id-type="pmid">29514064</pub-id>
</mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>S</given-names></string-name>, <string-name><surname>He</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2021</year>. <article-title>Dexmedetomidine ameliorates endotoxin-induced acute lung injury <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway</article-title>. <source>Redox Biol</source>. <volume>41</volume>:<fpage>101954</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2021.101954</pub-id>.<pub-id pub-id-type="pmid">33774474</pub-id>
</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>K.</given-names></string-name></person-group>
<year>2021</year>. <article-title>MicroRNA-23a reduces lipopolysaccharide-induced cellular apoptosis and inflammatory cytokine production through Rho-associated kinase 1/sirtuin-1/nuclear factor-kappa B crosstalk</article-title>. <source>Chin Med J (Engl)</source>. <volume>134</volume>(<issue>7</issue>):<fpage>829</fpage>&#x02013;<lpage>839</lpage>. doi: <pub-id pub-id-type="doi">10.1097/CM9.0000000000001369</pub-id>.<pub-id pub-id-type="pmid">33538509</pub-id>
</mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shin</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Oh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Moon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mun</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Roh</surname>
<given-names>SS.</given-names></string-name></person-group>
<year>2021</year>. <article-title><italic toggle="yes">Gardeniae fructus</italic> attenuates thioacetamide-induced liver fibrosis in mice via both AMPK/SIRT1/NF-&#x003ba;B pathway and Nrf2 signaling</article-title>. <source>Antioxidants (Basel)</source>. <volume>10</volume>(<issue>11</issue>):<fpage>1837</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox10111837</pub-id>.<pub-id pub-id-type="pmid">34829709</pub-id>
</mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suntharalingam</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Awuah</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Bruno</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Johnstone</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>YR</given-names></string-name>, <string-name><surname>Page</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Hemann</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Lippard</surname>
<given-names>SJ.</given-names></string-name></person-group>
<year>2015</year>. <article-title>Necroptosis-inducing rhenium<sup>V</sup> oxo complexes</article-title>. <source>J Am Chem Soc</source>. <volume>137</volume>(<issue>8</issue>):<fpage>2967</fpage>&#x02013;<lpage>2974</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ja511978y</pub-id>.<pub-id pub-id-type="pmid">25698398</pub-id>
</mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname>
<given-names>XL</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>YL</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>SY.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Resveratrol ameliorates sevoflurane-induced cognitive impairment by activating the SIRT1/NF-&#x003ba;B pathway in neonatal mice</article-title>. <source>J Nutr Biochem</source>. <volume>90</volume>:<fpage>108579</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jnutbio.2020.108579</pub-id>.<pub-id pub-id-type="pmid">33388350</pub-id>
</mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vladimirovna</surname>
<given-names>IL</given-names></string-name>, <string-name><surname>Sosunova</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nikolaev</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nenasheva</surname>
<given-names>T.</given-names></string-name></person-group>
<year>2016</year>. <article-title>Mesenchymal stem cells and myeloid derived suppressor cells: common traits in immune regulation</article-title>. <source>J Immunol Res</source>. <volume>2016</volume>:<fpage>7121580</fpage>&#x02013;<lpage>7121517</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/7121580</pub-id>.<pub-id pub-id-type="pmid">27529074</pub-id>
</mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>He</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>F.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats</article-title>. <source>Arch Biochem Biophys</source>. <volume>712</volume>:<fpage>109050</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.abb.2021.109050</pub-id>.<pub-id pub-id-type="pmid">34610336</pub-id>
</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>Z.</given-names></string-name></person-group>
<year>2013</year>. <article-title>Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages</article-title>. <source>Nat Commun</source>. <volume>4</volume>(<issue>1</issue>):<fpage>2106</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms3106</pub-id>.<pub-id pub-id-type="pmid">23820884</pub-id>
</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Chai</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Nicotinamide mononucleotide: an emerging nutraceutical against cardiac aging?</article-title>
<source>Curr Opin Pharmacol</source>. <volume>60</volume>:<fpage>291</fpage>&#x02013;<lpage>297</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coph.2021.08.006</pub-id>.<pub-id pub-id-type="pmid">34507029</pub-id>
</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mei</surname>
<given-names>S</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2021</year>. <article-title>Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury</article-title>. <source>J Neuroinflammation</source>. <volume>18</volume>(<issue>1</issue>):<fpage>2</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-020-02041-7</pub-id>.<pub-id pub-id-type="pmid">33402181</pub-id>
</mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Tsukasaki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nepal</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Di</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>X</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2020</year>. <article-title>IL-1&#x003b2; suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury</article-title>. <source>J Clin Invest</source>. <volume>130</volume>(<issue>7</issue>):<fpage>3684</fpage>&#x02013;<lpage>3698</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI136908</pub-id>.<pub-id pub-id-type="pmid">32298238</pub-id>
</mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>KS.</given-names></string-name></person-group>
<year>2016</year>. <article-title>SIRT1/3 activation by resveratrol attenuates acute kidney injury in a septic rat model</article-title>. <source>Oxid Med Cell Longev</source>. <volume>2016</volume>:<fpage>7296092</fpage>&#x02013;<lpage>7296012</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/7296092</pub-id>.<pub-id pub-id-type="pmid">28003866</pub-id>
</mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z.</given-names></string-name></person-group>
<year>2021</year>. <article-title>MicroRNA-499-5p targets SIRT1 to aggravate lipopolysaccharide-induced acute lung injury</article-title>. <source>Free Radic Res</source>. <volume>55</volume>(<issue>1</issue>):<fpage>71</fpage>&#x02013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10715762.2020.1863393</pub-id>.<pub-id pub-id-type="pmid">33307898</pub-id>
</mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoshino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Baur</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Imai</surname>
<given-names>SI.</given-names></string-name></person-group>
<year>2018</year>. <article-title>NAD<sup>+</sup> Intermediates: the biology and therapeutic potential of NMN and NR</article-title>. <source>Cell Metab</source>. <volume>27</volume>(<issue>3</issue>):<fpage>513</fpage>&#x02013;<lpage>528</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2017.11.002</pub-id>.<pub-id pub-id-type="pmid">29249689</pub-id>
</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y.</given-names></string-name></person-group>
<year>2021</year>. <article-title>The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-&#x003ba;B signal pathway</article-title>. <source>Mol Med</source>. <volume>27</volume>(<issue>1</issue>):<fpage>115</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s10020-021-00376-2</pub-id>.<pub-id pub-id-type="pmid">34544355</pub-id>
</mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>YD</given-names></string-name>, <string-name><surname>Muhetaerjiang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>An</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy</article-title>. <source>Biomaterials</source>. <volume>268</volume>:<fpage>120552</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120552</pub-id>.<pub-id pub-id-type="pmid">33307365</pub-id>
</mixed-citation></ref></ref-list></back></article>
